193 related articles for article (PubMed ID: 34986863)
1. Polycystic ovary syndrome phenotype does not have impact on oocyte morphology.
Uk A; Decanter C; Grysole C; Keller L; Béhal H; Silva M; Dewailly D; Robin G; Barbotin AL
Reprod Biol Endocrinol; 2022 Jan; 20(1):7. PubMed ID: 34986863
[TBL] [Abstract][Full Text] [Related]
2. Is polycystic ovarian morphology related to a poor oocyte quality after controlled ovarian hyperstimulation for intracytoplasmic sperm injection? Results from a prospective, comparative study.
Sigala J; Sifer C; Dewailly D; Robin G; Bruyneel A; Ramdane N; Lefebvre-Khalil V; Mitchell V; Decanter C
Fertil Steril; 2015 Jan; 103(1):112-8. PubMed ID: 25450303
[TBL] [Abstract][Full Text] [Related]
3. Association between hyperandrogenism and adverse pregnancy outcomes in patients with different polycystic ovary syndrome phenotypes undergoing
Ma L; Cao Y; Ma Y; Zhai J
Gynecol Endocrinol; 2021 Aug; 37(8):694-701. PubMed ID: 33703999
[TBL] [Abstract][Full Text] [Related]
4. Impact of endometriosis on oocyte morphology in IVF-ICSI: retrospective study of a cohort of more than 6000 mature oocytes.
Robin C; Uk A; Decanter C; Behal H; Collinet P; Rubod C; Barbotin AL; Robin G
Reprod Biol Endocrinol; 2021 Oct; 19(1):160. PubMed ID: 34656130
[TBL] [Abstract][Full Text] [Related]
5. Age, body weight and ovarian function affect oocyte size and morphology in non-PCOS patients undergoing intracytoplasmic sperm injection (ICSI).
Weghofer A; Kushnir VA; Darmon SK; Jafri H; Lazzaroni-Tealdi E; Zhang L; Albertini DF; Barad DH; Gleicher N
PLoS One; 2019; 14(10):e0222390. PubMed ID: 31647816
[TBL] [Abstract][Full Text] [Related]
6. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
Fraissinet A; Robin G; Pigny P; Lefebvre T; Catteau-Jonard S; Dewailly D
Hum Reprod; 2017 Aug; 32(8):1716-1722. PubMed ID: 28854589
[TBL] [Abstract][Full Text] [Related]
7. Polycystic ovary syndrome and maternal obesity affect oocyte size in in vitro fertilization/intracytoplasmic sperm injection cycles.
Marquard KL; Stephens SM; Jungheim ES; Ratts VS; Odem RR; Lanzendorf S; Moley KH
Fertil Steril; 2011 May; 95(6):2146-9, 2149.e1. PubMed ID: 21071018
[TBL] [Abstract][Full Text] [Related]
8. Outcome of intracytoplasmic sperm injection in patients with polycystic ovary syndrome or isolated polycystic ovaries.
Esinler I; Bayar U; Bozdag G; Yarali H
Fertil Steril; 2005 Oct; 84(4):932-7. PubMed ID: 16213846
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic variation in anti-Mullerian hormone (AMH) production per follicle in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovarian morphology (PCOM): an observational cross-sectional study.
Bhide P; Kulkarni A; Dilgil M; Dhir P; Shah A; Gudi A; Homburg R
Gynecol Endocrinol; 2017 Oct; 33(10):801-806. PubMed ID: 28454499
[TBL] [Abstract][Full Text] [Related]
10. Serum anti-Mullerian hormone levels in the main phenotypes of polycystic ovary syndrome.
Sahmay S; Atakul N; Oncul M; Tuten A; Aydogan B; Seyisoglu H
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):157-61. PubMed ID: 23806449
[TBL] [Abstract][Full Text] [Related]
11. Significance of metaphase II human oocyte morphology on ICSI outcome.
Rienzi L; Ubaldi FM; Iacobelli M; Minasi MG; Romano S; Ferrero S; Sapienza F; Baroni E; Litwicka K; Greco E
Fertil Steril; 2008 Nov; 90(5):1692-700. PubMed ID: 18249393
[TBL] [Abstract][Full Text] [Related]
12. Comparison of oocyte quality and intracytoplasmic sperm injection outcome in women with isolated polycystic ovaries or polycystic ovarian syndrome.
Sahu B; Ozturk O; Ranierri M; Serhal P
Arch Gynecol Obstet; 2008 Mar; 277(3):239-44. PubMed ID: 17899140
[TBL] [Abstract][Full Text] [Related]
13. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
[TBL] [Abstract][Full Text] [Related]
14. Structural and morphologic differences in human oocytes after in vitro maturation compared with standard in vitro fertilization.
Walls ML; Hart R; Keelan JA; Ryan JP
Fertil Steril; 2016 Nov; 106(6):1392-1398.e5. PubMed ID: 27565256
[TBL] [Abstract][Full Text] [Related]
15. Outcome of in-vitro oocyte maturation in patients with PCOS: does phenotype have an impact?
Mackens S; Pareyn S; Drakopoulos P; Deckers T; Mostinckx L; Blockeel C; Segers I; Verheyen G; Santos-Ribeiro S; Tournaye H; De Vos M
Hum Reprod; 2020 Oct; 35(10):2272-2279. PubMed ID: 32951028
[TBL] [Abstract][Full Text] [Related]
16. Impact of polycystic ovary syndrome on selected indicators of in vitro fertilization and intracytoplasmic sperm injection treatment success.
Beydoun HA; Stadtmauer L; Zhao Y; Russell H; Matson DO; Oehninger S
J Womens Health (Larchmt); 2009 May; 18(5):717-23. PubMed ID: 19368509
[TBL] [Abstract][Full Text] [Related]
17. Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome: IVM of oocytes versus controlled ovarian stimulation.
Mostinckx L; Segers I; Belva F; Buyl R; Santos-Ribeiro S; Blockeel C; Smitz J; Anckaert E; Tournaye H; De Vos M
Hum Reprod; 2019 Aug; 34(8):1595-1607. PubMed ID: 31347678
[TBL] [Abstract][Full Text] [Related]
18. Low risk of OHSS with follitropin delta use in women with different polycystic ovary syndrome phenotypes: a retrospective case series.
Yacoub S; Cadesky K; Casper RF
J Ovarian Res; 2021 Feb; 14(1):31. PubMed ID: 33579321
[TBL] [Abstract][Full Text] [Related]
19. [Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer].
Yu R; Lin J; Zhao JZ; Wang PY; Xiao SQ; Zhang W
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):250-4. PubMed ID: 22781109
[TBL] [Abstract][Full Text] [Related]
20. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
